Treatment of amyopathic dermatomyositis-associated interstitial lung disease

被引：0
|
作者：
Xiao, Ting
Xiao, Ting
机构：
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2015年 / 72卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
657
引用
收藏
页码：AB72 / AB72
页数：1
相关论文
共 50 条
  • [31] A case of Amyopathic Dermatomyositis associated with Interstitial Pulmonary Disease
    Ugan, Y.
    Sahin, M.
    Dogru, A.
    Bayram, D.
    Ceyhan, A. M.
    Tunc, S. E.
    CLINICA TERAPEUTICA, 2015, 166 (06): : 253 - 255
  • [32] The Predictive Risk Factors for Opportunistic Infection during Treatment for Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease
    Sugiyama, Yumiko
    Yoshimi, Ryusuke
    Tamura, Maasa
    Hamada, Naoki
    Nagai, Hideto
    Tsuchida, Naomi
    Kunishita, Yosuke
    Soejima, Yutaro
    Kishimoto, Daiga
    Kamiyama, Reikou
    Minegishi, Kaoru
    Kirino, Yohei
    Ohno, Shigeru
    Nakajima, Hideaki
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [33] Intravenous cyclophosphamide for the treatment of interstitial lung disease associated with amyopathic dermatomyositis, dermatomyositis and polymyositis: A comparative study with cyclosporine and azathioprine.
    Azuma, K
    Yamasaki, Y
    Yamasaki, M
    Okubo, M
    Yamada, H
    Ozaki, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S105 - S105
  • [34] Rapidly Progressive Interstitial Lung Disease In Clinically Amyopathic Dermatomyositis
    Mangardich, A.
    Zanoria, S.
    Kanaan, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [35] The Prognostic Value Of Interstitial Lung Disease In Polymyositis, Dermatomyositis, And Clinically Amyopathic Dermatomyositis
    Ikeda, S.
    Arita, M.
    Misaki, K.
    Takaiwa, T.
    Fukuda, Y.
    Tokioka, F.
    Tanaka, M.
    Ishida, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [36] THE PREDICTIVE PROGNOSTIC FACTORS FOR CLINICAL COURSE OF POLYMYOSITIS/DERMATOMYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Sugiyama, Y.
    Yoshimi, R.
    Tamura, M.
    Hamada, N.
    Nagai, H.
    Tsuchida, N.
    Soejima, Y.
    Kunishita, Y.
    Kishimoto, D.
    Nakano, H.
    Kamiyama, R.
    Minegishi, K.
    Asami, Y.
    Kirino, Y.
    Ohno, S.
    Nakajima, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 645 - 645
  • [37] Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease
    Hozumi, Hironao
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakashima, Ran
    Enomoto, Yasunori
    Suzuki, Yuzo
    Kono, Masato
    Karayama, Masato
    Furuhashi, Kazuki
    Murakami, Akihiro
    Inui, Naoki
    Nakamura, Yutaro
    Mimori, Tsuneyo
    Suda, Takafumi
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (09) : 1394 - 1401
  • [38] Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease The FLAIR Model
    Lian, Xinyue
    Zou, Jing
    Guo, Qiang
    Chen, Sheng
    Lu, Liangjing
    Wang, Ran
    Zhou, Mengmeng
    Fu, Qiong
    Ye, Yan
    Bao, Chunde
    CHEST, 2020, 158 (04) : 1535 - 1545
  • [39] Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
    Ting Li
    Li Guo
    Zhiwei Chen
    Liyang Gu
    Fangfang Sun
    Xiaoming Tan
    Sheng Chen
    Xiaodong Wang
    Shuang Ye
    Scientific Reports, 6
  • [40] Amyopathic Dermatomyositis And Interstitial Lung Disease Associated With Anti-Nxp2 Autoantibody
    Reed, T. P.
    Gupta, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345